K Pharma,Inc. (TYO:4896)
Japan flag Japan · Delayed Price · Currency is JPY
675.00
-11.00 (-1.60%)
Nov 18, 2026, 10:13 AM JST

K Pharma,Inc. Financials Overview

Millions JPY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---1,000--
Revenue Growth
------
Gross Profit
---910--
Operating Income
-1,013-916-836367-353-219
Net Income
-1,159-993-846260-392-228
Earnings Per Share
-99.76-85.57-72.9023.07-42.01-30.00
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2,0252,7912,2683,2661,336188
Total Debt
1,6241,500----
Net Cash (Debt)
4011,2912,2683,2661,336188
Net Cash Growth
-73.34%-43.08%-30.56%144.46%610.64%-
Net Cash Per Share
34.52111.25195.44289.79143.1824.73

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--918-983454--
Capital Expenditures
--11-14-9--
Free Cash Flow
--929-997445--
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---91.00%--
Operating Margin
---36.70%--
Pretax Margin
---30.00%--
Profit Margin
---26.00%--
FCF Margin
---44.50%--

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---32.14--
P/FCF Ratio
---18.78--
PS Ratio
---8.36--